These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6431316)

  • 1. Valproate treatment and carnitine deficiency.
    Ohtani Y; Matsuda I
    Neurology; 1984 Aug; 34(8):1128-9. PubMed ID: 6431316
    [No Abstract]   [Full Text] [Related]  

  • 2. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine, valproate, and toxicity.
    Coulter DL
    J Child Neurol; 1991 Jan; 6(1):7-14. PubMed ID: 2002205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity.
    Coulter DL
    Lancet; 1984 Mar; 1(8378):689. PubMed ID: 6142383
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle carnitine deficiency in patients using valproic acid.
    Shapira Y; Gutman A
    J Pediatr; 1991 Apr; 118(4 Pt 1):646-9. PubMed ID: 2007943
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

  • 9. Carnitine deficiency with valproate therapy.
    Stumpf DA; Parker WD; Haas R
    J Pediatr; 1983 Jul; 103(1):175-6. PubMed ID: 6408234
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate induced encephalopathy treated with carnitine in an adult.
    Beversdorf D; Allen C; Nordgren R
    J Neurol Neurosurg Psychiatry; 1996 Aug; 61(2):211. PubMed ID: 8708702
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate-induced coma with ketosis and carnitine insufficiency.
    Triggs WJ; Bohan TP; Lin SN; Willmore LJ
    Arch Neurol; 1990 Oct; 47(10):1131-3. PubMed ID: 2121122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
    Al-sharefi A; Bilous R
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26336183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 16. Intractable epilepsy.
    Shuper A; Gutman A; Mimouni M
    Lancet; 1999 Apr; 353(9160):1238. PubMed ID: 10217085
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia.
    Sofi A; Herial NA; Ali II
    Am J Ther; 2013; 20(6):e703-5. PubMed ID: 20224318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carnitine deficiency as an adverse effect of treatment with valproic acid].
    Opala G
    Neurol Neurochir Pol; 1990; 24(3-4):244-5. PubMed ID: 2131422
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A child with valproic acid-associated carnitine deficiency and carnitine-responsive cardiac dysfunction.
    Bratton SL; Garden AL; Bohan TP; French JW; Clarke WR
    J Child Neurol; 1992 Oct; 7(4):413-6. PubMed ID: 1281852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.